Anterix Financial Statements (ATEX)
|
|
Report date
|
|
|
28.05.2020 |
15.06.2021 |
26.05.2022 |
14.06.2023 |
26.06.2024 |
|
13.11.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1.56 |
0.921 |
1.08 |
1.92 |
4.19 |
|
5.61 |
Operating Income, bln rub |
|
|
-37.4 |
-54.8 |
-48.0 |
-54.9 |
-10.1 |
|
-53.4 |
EBITDA, bln rub |
? |
|
-33.7 |
-47.3 |
-46.5 |
-53.4 |
-51.6 |
|
-52.8 |
Net profit, bln rub |
? |
|
-37.6 |
-54.4 |
-37.5 |
-16.3 |
-9.13 |
|
-37.4 |
|
OCF, bln rub |
? |
|
-31.0 |
-9.96 |
17.9 |
-27.3 |
42.0 |
|
34.8 |
CAPEX, bln rub |
? |
|
4.43 |
14.2 |
27.4 |
27.1 |
17.3 |
|
17.8 |
FCF, bln rub |
? |
|
-35.4 |
-24.1 |
-9.50 |
-54.4 |
24.7 |
|
27.7 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
35.8 |
50.1 |
49.0 |
56.8 |
14.3 |
|
58.6 |
Cost of production, bln rub |
|
|
2.83 |
1.61 |
0.005 |
0.005 |
0.848 |
|
0.572 |
R&D, bln rub |
|
|
2.69 |
4.34 |
3.59 |
4.44 |
5.70 |
|
7.01 |
Interest expenses, bln rub |
|
|
0.000 |
0.000 |
0.056 |
0.000 |
0.000 |
|
0.000 |
|
Assets, bln rub |
|
|
267.4 |
253.1 |
278.0 |
278.6 |
324.9 |
|
317.2 |
Net Assets, bln rub |
? |
|
245.1 |
212.5 |
186.3 |
179.8 |
161.0 |
|
139.1 |
Debt, bln rub |
|
|
8.75 |
7.07 |
5.69 |
4.65 |
5.30 |
|
5.65 |
Cash, bln rub |
|
|
137.5 |
117.5 |
105.6 |
43.2 |
60.6 |
|
43.1 |
Net debt, bln rub |
|
|
-128.7 |
-110.5 |
-99.9 |
-38.5 |
-55.3 |
|
-37.5 |
|
Ordinary share price, rub |
|
|
45.7 |
47.2 |
57.9 |
33.0 |
33.6 |
|
31.0 |
Number of ordinary shares, mln |
|
|
16.4 |
17.4 |
18.1 |
18.8 |
18.8 |
|
18.6 |
|
Market cap, bln rub |
|
|
750 |
821 |
1 050 |
623 |
631 |
|
576 |
EV, bln rub |
? |
|
621 |
711 |
951 |
584 |
575 |
|
538 |
Book value, bln rub |
|
|
134 |
90 |
35 |
-22 |
-56 |
|
-83 |
|
EPS, rub |
? |
|
-2.29 |
-3.13 |
-2.07 |
-0.87 |
-0.49 |
|
-2.01 |
FCF/share, rub |
|
|
-2.15 |
-1.39 |
-0.52 |
-2.89 |
1.31 |
|
1.49 |
BV/share, rub |
|
|
8.13 |
5.19 |
1.94 |
-1.18 |
-2.97 |
|
-4.45 |
|
EBITDA margin, % |
? |
|
-2 158% |
-5 133% |
-4 290% |
-2 784% |
-1 232% |
|
-941.8% |
Net margin, % |
? |
|
-2 407% |
-5 910% |
-3 461% |
-850.3% |
-217.8% |
|
-666.5% |
FCF yield, % |
? |
|
-4.72% |
-2.94% |
-0.90% |
-8.74% |
3.91% |
|
4.81% |
ROE, % |
? |
|
-15.4% |
-25.6% |
-20.1% |
-9.08% |
-5.67% |
|
-26.9% |
ROA, % |
? |
|
-14.1% |
-21.5% |
-13.5% |
-5.86% |
-2.81% |
|
-11.8% |
|
P/E |
? |
|
-19.9 |
-15.1 |
-28.0 |
-38.2 |
-69.1 |
|
-15.4 |
P/FCF |
|
|
-21.2 |
-34.0 |
-110.6 |
-11.4 |
25.6 |
|
20.8 |
P/S |
? |
|
479.5 |
891.6 |
969.1 |
324.4 |
150.5 |
|
102.7 |
P/BV |
? |
|
5.62 |
9.08 |
29.9 |
-28.0 |
-11.3 |
|
-6.95 |
EV/EBITDA |
? |
|
-18.4 |
-15.0 |
-20.4 |
-10.9 |
-11.1 |
|
-10.2 |
Debt/EBITDA |
|
|
3.81 |
2.34 |
2.15 |
0.72 |
1.07 |
|
0.71 |
|
R&D/CAPEX, % |
|
|
60.8% |
30.6% |
13.1% |
16.4% |
32.9% |
|
39.3% |
|
CAPEX/Revenue, % |
|
|
283.0% |
1 539% |
2 529% |
1 414% |
413.7% |
|
318.3% |
|
Anterix shareholders |